Literature DB >> 18197272

Prefrontal executive function and D1, D3, 5-HT2A and 5-HT6 receptor gene variations in healthy adults.

Hsien-Yuan Lane1, Yi-Ching Liu, Chieh-Liang Huang, Ching-Liang Hsieh, Yi-Lin Chang, Lauren Chang, Yue-Cune Chang, Wen-Ho Chang.   

Abstract

OBJECTIVE: The Val158Met polymorphism of the catechol-O-methyltransferase gene has been demonstrated to be associated with prefrontal executive function explaining 4% of variance in perseverative errors on the Wisconsin Card Sorting Test (WCST). Studies suggest that dopamine D(1) and D(3) and serotonin 5-HT(2A) and 5-HT(6) receptors may also be involved in prefrontal cognitive function and that genetic polymorphisms (D(1) A-48G, D(3) Ser9Gly, 5-HT(2A) T102C, and 5-HT(6) T267C) of these receptors may be associated with brain glucose metabolism or neurophysiological function. The current study's objective was to investigate whether executive function varies with these genetic variations.
METHODS: A sample of 216 healthy Han Chinese adults were measured with the WCST and genotyped for the 4 genetic polymorphisms.
RESULTS: Kruskal-Wallis tests showed a significant difference in WCST perseverative errors among the genotypes D(3) Ser9Gly (p = 0.009), 5-HT(2A) T102C (p = 0.038) and 5-HT(6) T267C (p = 0.010), but not in the genotype D(1) A-48G. Multiple regression analysis for the WCST natural logarithm values (i.e., for fulfilling the normal distribution requirement) showed that subjects' perseverative errors were significantly influenced by D(1) A-48G, D(3) Ser9Gly, 5-HT(2A) T102C and 5-HT(6) T267C polymorphisms after adjustment of other variables.
CONCLUSION: The preliminary data suggest that D(1), D(3), 5-HT(2A) and 5-HT(6) genetic mutations may influence prefrontal executive cognition in healthy adults. Further studies in larger samples with other ethnicities or in mentally ill patients are warranted.

Entities:  

Keywords:  cognition; prefrontal; receptor, dopamine, D1; receptor, dopamine, D3; receptor, serotonin, 5-HT2A; receptor, serotonin, 5-HT6

Mesh:

Substances:

Year:  2008        PMID: 18197272      PMCID: PMC2186374     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  57 in total

1.  Modulation of memory fields by dopamine D1 receptors in prefrontal cortex.

Authors:  G V Williams; P S Goldman-Rakic
Journal:  Nature       Date:  1995-08-17       Impact factor: 49.962

2.  Relationship between homozygosity at the dopamine D3 receptor gene and schizophrenia.

Authors:  R Mant; J Williams; P Asherson; E Parfitt; P McGuffin; M J Owen
Journal:  Am J Med Genet       Date:  1994-03-15

3.  Heterozygote disadvantage in cystic fibrosis.

Authors:  M Super
Journal:  Lancet       Date:  1977-12-17       Impact factor: 79.321

Review 4.  Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria.

Authors:  Michael F Green; Keith H Nuechterlein; James M Gold; Deanna M Barch; Jonathan Cohen; Susan Essock; Wayne S Fenton; Fred Frese; Terry E Goldberg; Robert K Heaton; Richard S E Keefe; Robert S Kern; Helena Kraemer; Ellen Stover; Daniel R Weinberger; Steven Zalcman; Stephen R Marder
Journal:  Biol Psychiatry       Date:  2004-09-01       Impact factor: 13.382

5.  Association of risperidone treatment response with a polymorphism in the 5-HT(2A) receptor gene.

Authors:  Hsien-Yuan Lane; Yue-Cune Chang; Chih-Chiang Chiu; Mao-Liang Chen; Min-Hua Hsieh; Wen-Ho Chang
Journal:  Am J Psychiatry       Date:  2002-09       Impact factor: 18.112

6.  Adjuvant topiramate administration: a pharmacologic strategy for addressing NMDA receptor hypofunction in schizophrenia.

Authors:  Stephen I Deutsch; Barbara L Schwartz; Richard B Rosse; John Mastropaolo; Cherie L Marvel; Amy L Drapalski
Journal:  Clin Neuropharmacol       Date:  2003 Jul-Aug       Impact factor: 1.592

Review 7.  Neurobiology of emotion perception II: Implications for major psychiatric disorders.

Authors:  Mary L Phillips; Wayne C Drevets; Scott L Rauch; Richard Lane
Journal:  Biol Psychiatry       Date:  2003-09-01       Impact factor: 13.382

8.  Association study of a functional catechol-O-methyltransferase-gene polymorphism and cognitive function in healthy females.

Authors:  Shih Jen Tsai; Younger W-Y Yu; Tai Jui Chen; Jen Yeu Chen; Ying Jay Liou; Ming Chao Chen; Chen Jee Hong
Journal:  Neurosci Lett       Date:  2003-02-27       Impact factor: 3.046

9.  Association between clozapine response and allelic variation in 5-HT2A receptor gene.

Authors:  M Arranz; D Collier; M Sodhi; D Ball; G Roberts; J Price; P Sham; R Kerwin
Journal:  Lancet       Date:  1995-07-29       Impact factor: 79.321

Review 10.  What are the functional consequences of neurocognitive deficits in schizophrenia?

Authors:  M F Green
Journal:  Am J Psychiatry       Date:  1996-03       Impact factor: 18.112

View more
  23 in total

1.  An association study on the polymorphisms of dopaminergic genes with working memory in a healthy Chinese Han population.

Authors:  Pingyuan Gong; Hang Zhang; Wanyu Chi; Wanhua Ge; Kejin Zhang; Anyun Zheng; Xiaocai Gao; Fuchang Zhang
Journal:  Cell Mol Neurobiol       Date:  2012-02-24       Impact factor: 5.046

2.  Evaluating the role of serotonin on neuropsychological function after breast cancer using acute tryptophan depletion.

Authors:  Diane Von Ah; Todd Skaar; Fredrick Unverzagt; Menggang Yu; Jingwei Wu; Bryan Schneider; Anna Maria Storniolo; Lyndsi Moser; Kristin Ryker; Jennifer Milata; Janet S Carpenter
Journal:  Biol Res Nurs       Date:  2010-12-30       Impact factor: 2.522

3.  Acute effects of ayahuasca on neuropsychological performance: differences in executive function between experienced and occasional users.

Authors:  José Carlos Bouso; Josep Maria Fábregas; Rosa Maria Antonijoan; Antoni Rodríguez-Fornells; Jordi Riba
Journal:  Psychopharmacology (Berl)       Date:  2013-06-21       Impact factor: 4.530

4.  Acute and long-term effects of adolescent methylphenidate on decision-making and dopamine receptor mRNA expression in the orbitofrontal cortex.

Authors:  Leslie R Amodeo; Eliza Jacobs-Brichford; Matthew S McMurray; Jamie D Roitman
Journal:  Behav Brain Res       Date:  2017-02-14       Impact factor: 3.332

5.  Emotion moderates the association between HTR2A (rs6313) genotype and antisaccade latency.

Authors:  Mark Mills; Olivia Wieda; Scott F Stoltenberg; Michael D Dodd
Journal:  Exp Brain Res       Date:  2016-05-09       Impact factor: 1.972

6.  No observable relationship between the 12 genes of nervous system and reasoning skill in a young Chinese Han population.

Authors:  Pingyuan Gong; Fuchang Zhang; Xu Lei; Xiaodong Wu; Dongmei Chen; Wenjiang Zhang; Kejin Zhang; Anyun Zheng; Xiaocai Gao
Journal:  Cell Mol Neurobiol       Date:  2011-01-15       Impact factor: 5.046

Review 7.  Role of dopamine receptors in ADHD: a systematic meta-analysis.

Authors:  Jing Wu; Haifan Xiao; Hongjuan Sun; Li Zou; Ling-Qiang Zhu
Journal:  Mol Neurobiol       Date:  2012-05-19       Impact factor: 5.590

8.  Correlation between errors on the Wisconsin Card Sorting Test and the availability of striatal dopamine transporters in healthy volunteers.

Authors:  Pei Chun Hsieh; Tzung Lieh Yeh; I Hui Lee; Hui Chun Huang; Po See Chen; Yen Kuang Yang; Nan Tsing Chiu; Ru Band Lu; Mei-Hsiu Liao
Journal:  J Psychiatry Neurosci       Date:  2010-03       Impact factor: 6.186

9.  Focusing on symptoms rather than diagnoses in brain dysfunction: conscious and nonconscious expression in impulsiveness and decision-making.

Authors:  T Palomo; R J Beninger; R M Kostrzewa; T Archer
Journal:  Neurotox Res       Date:  2008-08       Impact factor: 3.911

10.  Evaluating the role of serotonin in hot flashes after breast cancer using acute tryptophan depletion.

Authors:  Janet S Carpenter; Menggang Yu; Jingwei Wu; Diane Von Ah; Jennifer Milata; Julie L Otte; Shelley Johns; Bryan Schneider; Anna Maria Storniolo; Ronald Salomon; Zeuresenay Desta; Donghua Cao; Yan Jin; Santosh Philips; Todd C Skaar
Journal:  Menopause       Date:  2009 Jul-Aug       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.